Recurrent herpes simplex labialis: viral replication and clinical course
- PMID: 217269
- DOI: 10.1097/00000441-197811000-00009
Recurrent herpes simplex labialis: viral replication and clinical course
Abstract
The purpose of this study was to provide additional information on the clinical course and viral replication kinetics of herpes simplex virus (HSV) in recurrent herpes labialis. Data were obtained on 20 subjects who were followed for five days from the first day of the lesion. HSV was isolated in 17 subjects (85%); 75% were positive on day 1 of the lesion. Median HSV titer on day 1 was 1.7 x 10(3)/0.2ml. Isolation rates and titers dropped sharply and virus could no longer be detected by day 4. The clinical course both in terms of the frequency and the severity of the symptoms paralleled the kinetics of viral replication. Thermography delineated location of subsequent lesions in three early symptomatic patients who were studied at the time when no visible lesions were observed. These data are felt to provide useful background information for future studies on the efficacy of topical antiviral agents.
Similar articles
-
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.N Engl J Med. 1977 Jul 14;297(2):69-75. doi: 10.1056/NEJM197707142970201. N Engl J Med. 1977. PMID: 194157
-
[The virological diagnosis of recurrent labial herpes].Stomatologiia (Mosk). 1991 Nov-Dec;(6):22-3. Stomatologiia (Mosk). 1991. PMID: 1666465 Russian.
-
The natural history of recurrent facial-oral infection with herpes simplex virus.J Infect Dis. 1978 Dec;138(6):897-905. doi: 10.1093/infdis/138.6.897. J Infect Dis. 1978. PMID: 216753
-
The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.Postgrad Med. 2010 Sep;122(5):1-6. doi: 10.3810/pgm.2010.09.2216. Postgrad Med. 2010. PMID: 20873400 Review.
-
An update on short-course intermittent and prevention therapies for herpes labialis.Herpes. 2007 Jun;14 Suppl 1:13A-18A. Herpes. 2007. PMID: 17877887 Review.
Cited by
-
Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.Antimicrob Agents Chemother. 2014;58(3):1273-8. doi: 10.1128/AAC.02150-13. Epub 2013 Dec 16. Antimicrob Agents Chemother. 2014. PMID: 24342632 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources